During the 11th Belgian Multidisciplinary Meeting on Urological Cancers (BMUC) 2024, Prof. Dr. Karolien Goffin (University Hospitals Leuven), Dr. Carlos Artigas (Institut Jules Bordet, Brussels) and Prof. Dr. Nadia Withofs (CHU de Liège) discussed the current challenges in implementing prostate-specific membrane antigen (PSMA) radioligand therapy in Belgium.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
